Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Buy

Price to Earnings Rating

Neutral

Analyst Rating

Strong Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Novartis AG (NVS)

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/07/1996

Market Cap

224,477,448,058

Shares Outstanding

2,277,480,000

Weighted SO

2,055,460,483

Total Employees

N/A

Upcoming Earnings

07/01/1998

Similar Tickers

AZN --.--%

GSK --.--%

RHHBY --.--%

BMY --.--%

SNY --.--%

MRK --.--%

BAYRY --.--%

GILD --.--%

JNJ --.--%

Beta

0.4920

Last Div

3.7800

Range

92.19-114.75

Chg

1.4250

Avg Vol

1319793

Mkt Cap

224477448058

Exch

NYSE

Country

CH

Phone

41 61 324 1111

DCF Diff

0.3803

DCF

114.1947

Div Yield

0.0329

P/S

4.6563

EV Multiple

12.8566

P/FV

5.5893

Div Yield %

3.2921

P/E

14.4208

PEG

0.1162

Payout

0.4713

Current Ratio

0.9305

Quick Ratio

0.7224

Cash Ratio

0.2862

DSO

64.2038

DIO

168.0006

Op Cycle

232.2043

DPO

121.1989

CCC

111.0054

Gross Margin

0.7410

Op Margin

0.2469

Pretax Margin

0.2267

Net Margin

0.3355

Eff Tax Rate

0.0745

ROA

0.1659

ROE

0.3892

ROCE

0.1703

NI/EBT

1.4799

EBT/EBIT

0.9184

EBIT/Rev

0.2469

Debt Ratio

0.2813

D/E

0.6572

LT Debt/Cap

0.3203

Total Debt/Cap

0.3966

Int Coverage

13.1358

CF/Debt

0.5493

Equity Multi

2.3364

Rec Turnover

5.6850

Pay Turnover

3.0116

Inv Turnover

2.1726

FA Turnover

4.5386

Asset Turnover

0.4944

OCF/Share

7.4102

FCF/Share

5.7624

Cash/Share

4.1490

OCF/Sales

0.3125

FCF/OCF

0.7776

CF Coverage

0.5493

ST Coverage

1.9404

CapEx Coverage

4.4970

Div&CapEx Cov

1.3728

P/BV

5.5893

P/B

5.5893

P/S

4.6563

P/E

14.4208

P/FCF

19.1615

P/OCF

15.4833

P/CF

15.4833

PEG

0.1162

P/S

4.6563

EV Multiple

12.8566

P/FV

5.5893

DPS

3.7772

Latest Headlines (EST)

GlobeNewswire Inc. Jun 12, 06:00 Novartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in new population of patients with PNH GlobeNewswire Inc. Jun 02, 05:15 Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer GlobeNewswire Inc. May 08, 04:49 SoulGen Revolutionizes NSFW Content Creation with Industry-Leading NSFW AI Video Generator GlobeNewswire Inc. May 07, 06:00 Dental Consumables Market Projected to Hit USD 70.55 Billion by 2032 Amid Rising Demand for Aesthetic and Restorative Dental Care – SNS Insider GlobeNewswire Inc. Apr 03, 00:13 Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN) GlobeNewswire Inc. Feb 23, 23:30 Composite Dental Restorative Material Market to Reach $887.02 Million, by 2032 at 7.2% CAGR: Allied Market Research GlobeNewswire Inc. Feb 20, 23:30 Dental Grinding and Polishing Burs Market to Reach $756.35 Million By 2032 at 5% CAGR: Allied Market Research GlobeNewswire Inc. Feb 01, 01:14 Annovis Bio, Inc. Announces Proposed Public Offering GlobeNewswire Inc. Dec 30, 05:45 Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA The Motley Fool Dec 01, 20:45 2 Dividend Stocks to Buy and Hold Forever GlobeNewswire Inc. Nov 11, 23:00 MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis GlobeNewswire Inc. Oct 26, 23:50 Novartis oral Fabhalta® (iptacopan) sustained clinically meaningful results at one year in Phase III C3 glomerulopathy (C3G) trial GlobeNewswire Inc. Sep 16, 01:30 3D Technologies Transform Dental Laboratory Market is forecasted to reach USD 99,300 million by 2034, Delivering High Accuracy and Efficiency in Dental Applications GlobeNewswire Inc. Aug 22, 21:30 Targeted Therapeutics Market is Pioneering Growth Towards a USD 118.6 Billion Milestone by 2031, with a CAGR of 6.4% - Exclusive Report by Transparency Market Research, Inc. GlobeNewswire Inc. Aug 21, 22:30 Strategic Opportunities in Thin Film Drug Manufacturing Market to Expand to USD 16.5 Billion by 2034, Driving Industry Growth | Transparency Market Research Inc. GlobeNewswire Inc. Aug 12, 21:00 Monoclonal Antibodies Market Size is Surpassing USD 650.49 Billion by 2033, Growing at Projected 12.0% CAGR GlobeNewswire Inc. Jul 30, 06:00 Global Regenerative Medicine Market Size To Worth USD 349.93 Billion By 2033 | CAGR of 27.06% Zacks Investment Research Jul 24, 13:32 Is a Beat in the Cards for Incyte (INCY) in Q2 Earnings? - Zacks Investment Research Benzinga Jul 03, 03:38 TSLA, PARA, ANVS, LLY, AMZN: Top 5 Trending Stocks Today - Annovis Bio (NYSE:ANVS), Amazon.com (NASDAQ ... - Benzinga Zacks Investment Research Jan 18, 18:15 Novartis (NVS) Stock Slides as Market Rises: Facts to Know Before You Trade

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
3.78 09/24/2024 11/30/-0001 03/08/2024 11/30/-0001
3.78 03/07/2024 02/12/2024 03/08/2024 04/19/2024
3.47 03/09/2023 02/02/2023 03/10/2023 03/20/2023
3.36 03/08/2022 02/03/2022 03/09/2022 03/17/2022
3.38 03/04/2021 01/26/2021 03/05/2021 03/15/2021
3.04 03/03/2020 01/31/2020 03/04/2020 03/12/2020
2.57 03/04/2019 01/31/2019 03/05/2019 03/13/2019
2.67 03/06/2018 11/30/-0001 03/07/2018 04/25/2018
2.46 03/01/2017 01/27/2017 03/03/2017 04/20/2017
2.47 02/24/2016 02/01/2016 02/26/2016 04/15/2016
2.52 03/02/2015 11/30/-0001 11/30/-0001 04/20/2015
2.72 02/27/2014 02/04/2014 03/03/2014 04/10/2014
2.27 02/26/2013 02/11/2013 02/28/2013 04/05/2013
2.20 02/27/2012 11/30/-0001 11/30/-0001 04/05/2012
2.36 02/24/2011 11/30/-0001 11/30/-0001 04/08/2011
1.95 03/02/2010 11/30/-0001 11/30/-0001 11/30/-0001
1.54 02/24/2009 11/30/-0001 11/30/-0001 11/30/-0001
1.54 02/26/2008 11/30/-0001 11/30/-0001 11/30/-0001
0.97 03/06/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.89 02/28/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.72 02/24/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.63 03/04/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.47 03/21/2002 11/30/-0001 11/30/-0001 11/30/-0001
0.45 03/22/2001 11/30/-0001 11/30/-0001 11/30/-0001
0.97 11/14/2000 11/30/-0001 11/30/-0001 11/30/-0001